203 related articles for article (PubMed ID: 33852445)
21. Outcomes Analysis of Children Diagnosed With Hemophagocytic Lymphohistiocytosis in the PICU.
Gregory J; Greenberg J; Basu S
Pediatr Crit Care Med; 2019 Apr; 20(4):e185-e190. PubMed ID: 30520798
[TBL] [Abstract][Full Text] [Related]
22. Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19.
Yang K; Xing MY; Jiang LY; Cai YP; Yang LL; Xie NN; Chen J; Wang WX; Wang L; Zhu JL; Zhang DY; Ruan QR; Song JX
Curr Med Sci; 2021 Feb; 41(1):39-45. PubMed ID: 33582903
[TBL] [Abstract][Full Text] [Related]
23. Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis.
Lehmberg K; McClain KL; Janka GE; Allen CE
Pediatr Blood Cancer; 2014 Nov; 61(11):2101-3. PubMed ID: 24753034
[TBL] [Abstract][Full Text] [Related]
24. Hemophagocytic Lymphohistiocytosis: Potentially Underdiagnosed in Intensive Care Units.
Lachmann G; Spies C; Schenk T; Brunkhorst FM; Balzer F; La Rosée P
Shock; 2018 Aug; 50(2):149-155. PubMed ID: 30010630
[TBL] [Abstract][Full Text] [Related]
25. Etiologies and Clinical Outcomes of Patients With Secondary Hemophagocytic Lymphohistiocytosis at a Tertiary PICU.
Dao D; Xoay TD; Galeano BK; Phuc PH; Ouellette Y
Pediatr Crit Care Med; 2019 Jul; 20(7):e311-e318. PubMed ID: 31149968
[TBL] [Abstract][Full Text] [Related]
26. Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
Knaak C; Schuster FS; Spies C; Vorderwülbecke G; Nyvlt P; Schenk T; Balzer F; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
Shock; 2020 Jun; 53(6):701-709. PubMed ID: 31626037
[TBL] [Abstract][Full Text] [Related]
27. Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome.
Fardet L; Coppo P; Kettaneh A; Dehoux M; Cabane J; Lambotte O
Arthritis Rheum; 2008 May; 58(5):1521-7. PubMed ID: 18438821
[TBL] [Abstract][Full Text] [Related]
28. [Hemophagocytic lymphohistiocytosis in critically ill patients].
Eichenauer DA; Lachmann G; La Rosée P
Med Klin Intensivmed Notfmed; 2021 Mar; 116(2):129-134. PubMed ID: 33580314
[TBL] [Abstract][Full Text] [Related]
29. Hemophagocytic Lymphohistiocytosis in the Medical ICU: A Single-Institution Cohort Study on Acute Liver Failure and Mortality.
Al Nasrallah N; Al-Hader A; Samala N; Sears CR
Crit Care Explor; 2021 Jan; 3(1):e0318. PubMed ID: 33458685
[TBL] [Abstract][Full Text] [Related]
30. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults.
Hines MR; von Bahr Greenwood T; Beutel G; Beutel K; Hays JA; Horne A; Janka G; Jordan MB; van Laar JAM; Lachmann G; Lehmberg K; Machowicz R; Miettunen P; La Rosée P; Shakoory B; Zinter MS; Henter JI
Crit Care Med; 2022 May; 50(5):860-872. PubMed ID: 34605776
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting.
Saeed H; Woods RR; Lester J; Herzig R; Gul Z; Monohan G
Int J Hematol; 2015 Aug; 102(2):195-9. PubMed ID: 25997871
[TBL] [Abstract][Full Text] [Related]
32. Serum soluble interleukin-2 receptor (sIL-2R) is an accurate biomarker for dengue-associated hemophagocytic lymphohistiocytosis syndrome diagnosed by Hscore.
Mahabala C; Koushik VK; Manjrekar PA; Balanthimogru P
Infection; 2023 Apr; 51(2):433-438. PubMed ID: 35999341
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic strategy for trigger identification in severe reactive hemophagocytic lymphohistiocytosis: A diagnostic accuracy study.
Tudesq JJ; Valade S; Galicier L; Zafrani L; Boutboul D; de Bazelaire C; Munoz-Bongrand N; Canet E; Ardisson F; Lemiale V; Darmon M; Azoulay E; Mariotte E
Hematol Oncol; 2021 Feb; 39(1):114-122. PubMed ID: 33099794
[TBL] [Abstract][Full Text] [Related]
34. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.
Minoia F; Bovis F; Davì S; Insalaco A; Lehmberg K; Shenoi S; Weitzman S; Espada G; Gao YJ; Anton J; Kitoh T; Kasapcopur O; Sanner H; Merino R; Astigarraga I; Alessio M; Jeng M; Chasnyk V; Nichols KE; Huasong Z; Li C; Micalizzi C; Ruperto N; Martini A; Cron RQ; Ravelli A; Horne A;
J Pediatr; 2017 Oct; 189():72-78.e3. PubMed ID: 28807357
[TBL] [Abstract][Full Text] [Related]
35. Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
Kurozumi A; Takahashi H; Watanabe T; Iwasaki Y
Thorac Cancer; 2021 May; 12(10):1625-1628. PubMed ID: 33783978
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the HScore as a predictor of disease outcome in patients with COVID-19.
Bordbar M; Sanaei Dashti A; Amanati A; Shorafa E; Mansoori Y; Dehghani SJ; Molavi Vardanjani H
BMC Pulm Med; 2021 Oct; 21(1):338. PubMed ID: 34715834
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
[TBL] [Abstract][Full Text] [Related]
38. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.
Bode SF; Ammann S; Al-Herz W; Bataneant M; Dvorak CC; Gehring S; Gennery A; Gilmour KC; Gonzalez-Granado LI; Groß-Wieltsch U; Ifversen M; Lingman-Framme J; Matthes-Martin S; Mesters R; Meyts I; van Montfrans JM; Pachlopnik Schmid J; Pai SY; Soler-Palacin P; Schuermann U; Schuster V; Seidel MG; Speckmann C; Stepensky P; Sykora KW; Tesi B; Vraetz T; Waruiru C; Bryceson YT; Moshous D; Lehmberg K; Jordan MB; Ehl S;
Haematologica; 2015 Jul; 100(7):978-88. PubMed ID: 26022711
[TBL] [Abstract][Full Text] [Related]
39. Screening of hemophagocytic lymphohistiocytosis in children with severe sepsis in pediatric intensive care.
El-Sayed ZA; El-Owaidy RH; Khamis MA; Rezk AR
Sci Prog; 2021; 104(3):368504211044042. PubMed ID: 34519554
[TBL] [Abstract][Full Text] [Related]
40. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy M; Atagündüz P; Atagündüz I; Sucak GT
Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
